Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20190113042346N2Phase 2Completed
Phase 2, randomised, double-blind trial of bupivacaine in shoulder pain (2 arms), sponsored by North Khorasan University of Medical Sciences. Primary endpoint: Post-laparoscopic shoulder pain intensity. Started Jan 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20190113042346N2.